These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 351463

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C, Ferrante P.
    Minerva Med; 1974 Apr 18; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract] [Full Text] [Related]

  • 4. [The treatment of ischemic cerebral accidents with pervincamine].
    Warot P, Caron JC.
    Lille Med; 1971 Apr 18; 16():S 2:6l4-9. PubMed ID: 5162101
    [No Abstract] [Full Text] [Related]

  • 5. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
    Bernini FP, Smaltino F.
    Acta Neurol (Napoli); 1974 Mar 18; 29(2):170-84. PubMed ID: 4849693
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
    Riccardi T, Passeri F, Locatelli F.
    Minerva Med; 1978 Sep 15; 69(42):2873-8. PubMed ID: 358021
    [Abstract] [Full Text] [Related]

  • 9. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography].
    Ardito R.
    Clin Ter; 1979 Mar 15; 88(5):461-12. PubMed ID: 466968
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
    Desruelles J, Camart JF.
    LARC Med; 1981 Dec 15; 1(3):86-90. PubMed ID: 7349693
    [No Abstract] [Full Text] [Related]

  • 11. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
    Lanfranchi M, Magnani G, Sinforiani E, Casali R.
    Int J Clin Pharmacol Res; 1984 Dec 15; 4(4):307-12. PubMed ID: 6389380
    [Abstract] [Full Text] [Related]

  • 12. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P.
    Brux Med; 1979 May 15; 59(5):279-85. PubMed ID: 380784
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P.
    Arzneimittelforschung; 1978 May 15; 28(11):2165-8. PubMed ID: 582924
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
    Petronio G, Scali G, Casa B, Nonis E.
    Clin Ter; 1980 Aug 31; 94(4):427-44. PubMed ID: 6257445
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke.
    Dekoninck WJ, Jocquet P, Jacquy J, Henriet M.
    Arzneimittelforschung; 1978 Aug 31; 28(9):1654-7. PubMed ID: 383107
    [Abstract] [Full Text] [Related]

  • 18. [Effects of vincamine treatment on cerebral arteriosclerotic vasculopathy].
    Saba GC, Locci P, Sgromo V, Gaspa F.
    G Clin Med; 1976 Aug 31; 56(2):149-55. PubMed ID: 964523
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.